Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Select Medical Holdings (SEM) Interest Expenses (2018 - 2026)

Select Medical Holdings (SEM) has disclosed Interest Expenses for 9 consecutive years, with $28.3 million as the latest value for Q1 2026.

  • For Q1 2026, Interest Expenses fell 2.53% year-over-year to $28.3 million; the TTM value through Mar 2026 reached $117.2 million, changed 0.18%, while the annual FY2025 figure was $117.9 million, 8.29% down from the prior year.
  • Interest Expenses hit $28.3 million in Q1 2026 for Select Medical Holdings, down from $28.9 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $50.3 million in Q3 2023 and bottomed at $6.3 million in Q4 2023.
  • Average Interest Expenses over 5 years is $33.3 million, with a median of $30.0 million recorded in 2025.
  • Year-over-year, Interest Expenses tumbled 59.71% in 2023 and then skyrocketed 351.33% in 2024.
  • Select Medical Holdings' Interest Expenses stood at $15.7 million in 2022, then crashed by 59.71% to $6.3 million in 2023, then surged by 351.33% to $28.6 million in 2024, then increased by 1.12% to $28.9 million in 2025, then dropped by 1.85% to $28.3 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods came in at $28.3 million, $28.9 million, and $30.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.